LSI Europe

VenstraMedical will be attending LSI Europe '25, Medtech's premier partnering event held this September in London-be sure to connect with our CEO, Martin Cook, if you are planning to attend! #LSIAlumni #LSIEurope25 #medtech #healthtech Suku Thambar Jordon Honeck Sandi Klemann LSI

Look forward to presenting our company Adtec Healthcare Limited at LSI Europe in London. We are still buzzing after closing our $12m funding round last week and happy to share what we have learned on the journey and our big plans. LSI #LSIEurope25 #coldplasma

Venstra Medical (#LSIEurope25 Presenter) has developed what it believes to be the world’s smallest and most powerful percutaneous ventricular assist device (pVAD) for treating cardiogenic shock. This breakthrough pVAD technology delivers over 7L/min of flow at physiological pressures, offering full left ventricular support in the cath lab using no catheter or sheath larger than 9Fr. With 7 granted patents, the system is designed for rapid deployment, minimal blood trauma, and total support, an approach shown to reduce infarct size in heart attack patients. Recent studies, including the DanGer Shock trial, continue to validate the use of pVADs for patients in cardiogenic shock, reinforcing the clinical relevance of Venstra Medical’s innovation. The company has recently achieved several major milestones: • Awarded a $1 million grant from MTPConnect’s Targeted Translation Research Accelerator (TTRA), part of Australia’s Medical Research Future Fund. (June 2025) • Featured in Forbes Australia for its innovation and recent funding. (June 2025) • Successfully demonstrated 20-day duration benchmarks using advanced in vitro testing, as well as multi-day endpoints in early chronic animal models delivering exceptional hydraulic performance, low hemolysis, and ease of implantation. (June 2025) Congratulations to the Venstra Medical team on all of the recent success. We’re excited to announce that Co-Founder and CEO Martin Cook has been selected to present Venstra Medical at LSI Europe ‘25 this September 7-11 in London. Join us in London to meet with Martin and learn more about Venstra Medical.

The program for LSI Europe ‘25 is live! See the program here: https://lnkd.in/dh8qXqfY Here are a few highlights from the program: • Keynotes from Carey Smith (Unorthodox Ventures), Dirk Barten (Intuitive), and Amira ROMANI (Siemens Healthineers) • Fireside chats with Antoine Papiernik (Sofinnova Partners) and Harry Stebbings (20VC) • Over 200 presenting companies The full program and preview of confirmed attendees are available now on our website. Even more sessions will be added over the coming weeks, so stay tuned. Register for LSI Europe ‘25 today to take full advantage of current pricing. Rates increase on August 1st. #LSIEurope25

I’m honored to have been selected as a speaker at LSI Europe '25, taking place in London, September 7–11. At the conference, I’ll be presenting on behalf of Leucadia Therapeutics to share our latest work on Arethusta—our innovative, implantable device designed to treat Alzheimer’s disease. I’ll also be unveiling our plans for first-in-human studies launching this Fall. Looking forward to connecting with fellow innovators, clinicians, and investors working to change the future of neurodegenerative care. #LSIEurope25 #Alzheimers #MedTech #Neurotech #Innovation #Arethusta #FirstInHuman #LeucadiaTherapeutics

Attend the session and walk away with the full market dive deck! On Wednesday, July 30th our team is hosting a virtual session featuring exclusive data and expert insights on the trends shaping the Medtech landscape across the European market. Welcome to Europe Market Dive Sign up for the session here ➝ https://lu.ma/95y8j460 Topics covered will include: • Market Insights • Industry Trends • Market Snapshot • LSI Europe Presenters • Audience Q&A Date & Time: • July 30th, 8:00 AM - 9:00 AM (PDT) Register using the link above to join the session. See you there. This session is part of our commitment to delivering trusted, data-backed market intelligence, and it's your opportunity to stay ahead in one of medtech’s fastest-growing regions.

Adtec Healthcare Limited has raised $12 million in funding led by AIPO Fund, with participation from SG Biomedical. The investment will support global expansion, accelerate new product development, and enable the company’s entry into the U.S. market. A spin-out from Japan’s Adtec Plasma Technology Co., Ltd., Adtec Healthcare was established in June 2023 and builds on more than 20 years of Cold Plasma expertise. The company launched the first medical Cold Plasma device of its kind, now used across Europe for advanced wound care and infection control. The company’s SteriPlas Cold Plasma medical device is a strong antibacterial with proven clinical efficacy for the management of chronic wounds, surgical site infections, and diabetic foot ulcers, typically complicated with antimicrobial resistance (AMR) and biofilm. Where conventional therapies, such as antibiotics, fail to destroy superbugs protected within biofilm, leading to a worsening infection, the SteriPlas delivers a quick, painless, and fast-acting solution with faster treatment times than standard of care and reduced hospital stays. Congratulations to LSI Alumni Mary McGovern and the entire Adtec Healthcare team on this major milestone. We’re excited to announce that CEO Mary McGovern has been selected to present Adtec Healthcare at LSI Europe ‘25 this September 7-11 in London. Join us in London to meet with Mary and learn more about Adtec Healthcare. #LSIEurope25

The countdown to LSI Europe ‘25 is on, and today we’re highlighting our 5 most recently announced panel sessions for the event: 1. Signature Series: The OrganOx Story • Roger Brooks (Moderator) — Founder, CEO, RBrooks Group • Oern Stuge — Executive Chairman, OrganOx • Samuel Levy — Founding Partner, LAUXERA CAPITAL PARTNERS 2. How to Build a Medtech Unicorn: From Dream to Reality • Manish Chand MD MBA PhD — OstomySecure • Tanya Ridding — Invenia Group • Mark Slack — CMR Surgical • Dan Stoyanov — Touch Surgery 3. The Future of Early-Stage Medtech Investing: A Global Outlook • C David Adair MD, MBA, FACOG, FASH, C-EFM — Managing Partner, Co-founder, Solas BioVentures • Bibi Sattar Marques — Partner, Buenavista Equity Partners (formerly GED Capital) • Branden Rosenhan MD — Founding Partner, MedMountain Ventures • Robert Hornby - Mercia Ventures — Investment Director, Mercia Ventures 4. Surgery in a Digital World: From Training to the OR • Erin MacKean — Co-Founder & Chief Operating Officer, Takaya Technology Inc. • Claartje Ypma — CEO & Co-founder, Augmedit • Ali Haddad — CEO & Founder, XARlabs • Manios Dimitrakakis — CEO, Panda Surgical 5. The Irish Advantage: A Hub for International Growth • Joey Mason — Venture Partner, Claret Capital Partners • Eamon Brady — CEO, WhiteSwell • Caroline Gaynor — Partner, Lightstone Ventures • Wayne Allen — Co-Founder & CEO, Perfuze Want to join us at LSI Europe ‘25? Price increases on August 1st. Register on our website today for your opportunity to connect with the industry's top decision-makers at LSI Europe ‘25 on September 7-11 in London. #LSIEurope25

SANTÉ Ventures, an early-stage healthcare and life sciences investment firm, is set to join us at LSI Europe ‘25. In 2024, the firm launched Fund V, continuing its focus on strategic investments in early-stage Biotech, Healthtech, and Medtech companies. Santé often leads or co-leads Seed and Series A rounds, frequently serving as the first institutional investor or even co-creating the company from the ground up alongside entrepreneurs. Their portfolio includes companies like: • CardiacBooster (Florian Ludwig) • Clairity, Inc. (Jeffrey R. Luber) • KēlaHealth (Bora Chang, MD) • Kestrel Therapeutics (Frank Haluska, MD, PhD) • Solu Therapeutics (Phil Vickers) and more... Join us in welcoming Managing Director, Dennis McWilliams, and Principal, Auriel August, MD, to LSI Europe ‘25 this September 7-11 in London. Want to join us at LSI Europe ‘25? Price increases on August 1st. Register on our website today for your opportunity to connect with the industry's top decision-makers at LSI Europe ‘25 on September 7-11 in London.

Connected Consumables is a Medtech startup transforming the clinical infusion workflows. The company’s patented technology enables real-time data transfer through medial fluid lines, creating the first connected consumables that integrate with clinical workflows. This connectivity enables automation of today’s manual infusion workflows, ultimately giving healthcare professionals more time to focus on patient-interaction and clinical decision-making, which are the heart of quality care. Connected Consumables has recently reached several important milestones, including: • Received FDA guidance for its 510(k) regulatory pathway • Achieved ISO 13485 certification • Submitted its first software as a medical device for the EU market • Filed five additional patents, supported by a scalable injection molding process and a full-functionality demonstrator • Collected insights from over 50 nurses and pharmacists across three leading U.S. oncology centers to optimize clinical usability We’re excited to announce that CEO Nora Herzog has been selected to present Connected Consumables at LSI Europe ‘25 this September 7-11 in London. Join us in London to meet with Nora and learn more about Connected Consumables. #LSIEurope25